Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin (2023 - 2024)

Historic EBITDA Margin for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2024 value amounting to 5603.19%.

  • Artiva Biotherapeutics' EBITDA Margin changed N/A to 5603.19% in Q1 2024 from the same period last year, while for Dec 2024 it was 26219.12%, marking a year-over-year change of. This contributed to the annual value of 26219.12% for FY2024, which is 261342900.0% down from last year.
  • According to the latest figures from Q1 2024, Artiva Biotherapeutics' EBITDA Margin is 5603.19%.
  • Artiva Biotherapeutics' 5-year EBITDA Margin high stood at 42.85% for Q3 2023, and its period low was 5603.19% during Q1 2024.